Where does Ancilia Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ancilia Bio's 1 recorded funding rounds.

Premier Alternatives

Ancilia Bio

Drug Discovery · New York, NY · Founded 2019 · Privately Held (backing)

Developer of virus-resistant live bacterial products designed to modulate the human microbiome. Ancilia Bio is based in New York, NY and was founded in 2019. It was valued at $28 million at its seed round in Apr 2026, the last priced event on record. It has raised $11.1 million across 1 recorded round; the latest was an early-stage round in Apr 2023.

PMV mark · valuation

$28.0M

Oct 2026

Priced at

its seed round

Apr 2026

Total raised

$11.1M

Last round

Early Stage VC

Apr 2023

Cap table — not yet on record

Ancilia Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Ancilia Bio with a free account

·The complete investor list: 13 names
·Watch Ancilia Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Ancilia Bio

Where does Ancilia Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ancilia Bio's 1 recorded funding rounds.